biopharma companies: Expect Syngene revenue to grow from high single digits to low double digits next year: Jonathan Hunt
Jonathan Hunt, MD & CEO, Syngene International, says the company deployed $55 million last year. Next year, they will be a little bit ahead of that – about $60 million. There are the usual themes within their business – automation, digitisation, improving productivity through an upgrading of technologies. About half of that should go towards … Read more
/cdn.vox-cdn.com/uploads/chorus_asset/file/25137774/STK115_Reddit_04.jpg)